NLRP3 and neoplasm: In CAR-T-cell-treated tumor cells, the robust CAP released a large amount of ATP, which activated NLRP3-mediated inflammasome and pyroptosis in tumor-infiltrating macrophages, leading to the release of cytokines such as IL-1β (53).